Personas / Equipo Humano

Emma Barroso Fernández

Buscador de publicaciones

Publicaciones

  • Botteri G, Salvadó L, Gumà A, Lee Hamilton D, Meakin PJ, Montagut G, Ashford MLJ, Ceperuelo-Mallafré V, Fernández-Veledo S, Vendrell J, Calderón-Dominguez M, Serra D, Herrero L, Pizarro J, Barroso E, Palomer FX and Vazquez M.

    The BACE1 product sAPPß induces ER stress and inflammation and impairs insulin signaling.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 85: 59-75. Nº de citas: 31

    [doi:10.1016/j.metabol.2018.03.005]

  • Palomer FX, Barroso E, Pizarro J, Peña L, Botteri G, Zarei M, Aguilar D, Montori M and Vazquez M.

    PPARß/d: A Key Therapeutic Target in Metabolic Disorders.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 19(3): . Nº de citas: 73

    [doi:10.3390/ijms19030913]

  • Palomer FX, Pizarro J, Barroso E and Vazquez M.

    Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 29(3): 178-190. Nº de citas: 359

    [doi:10.1016/j.tem.2017.11.009]

  • Zarei M, Barroso E, Palomer FX, Dai J, Rada P, Quesada T, Escolà-Gil JC, Cedó L, Zali MR, Molaei M, Dabiri R, Vázquez S, Pujol E, Valverde ÁM, Villarroya-Gombau F, Liu Y, Wahli W and Vazquez M.

    Hepatic regulation of VLDL receptor by PPARß/d and FGF21 modulates non-alcoholic fatty liver disease.

    molecular metabolism . 8: 117-131. Nº de citas: 79

    [doi:10.1016/j.molmet.2017.12.008]

  • Botteri G, Montori M, Gumà A, Pizarro J, Cedó L, Escolà-Gil JC, Li D, Barroso E, Palomer FX, Kohan AB and Vazquez M.

    VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.

    Diabetologia . 60(11): 2262-2273. Nº de citas: 29

    [doi:10.1007/s00125-017-4401-5]

  • Rodríguez-Calvo R, Chanda D, Oligschlaeger Y, Miglianico M, Coumans WA, Barroso E, Tajes M, Luiken JJ, Glatz JF, Vazquez M and Neumann D.

    Small heterodimer partner (SHP) contributes to insulin resistance in cardiomyocytes.

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE . 1862(5): 541-551. Nº de citas: 9

    [doi:10.1016/j.bbalip.2017.02.006]

  • Palomer FX, Barroso E, Zarei M, Botteri G and Vazquez M.

    PPAR beta/delta and lipid metabolism in the heart

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS . 1861(10): 1569-1578. Nº de citas: 38

    [doi:10.1016/j.bbalip.2016.01.019]

  • Toral M, Romero M, Jiménez R, Mahmoud AM, Barroso E, Gómez-Guzmán M, Sánchez M, Cogolludo Á, García-Redondo AB, Briones AM, Vazquez M, Pérez-Vizcaíno F and Duarte J.

    Carnitine palmitoyltransferase-1 up-regulation by PPAR-ß/d prevents lipid-induced endothelial dysfunction.

    CLIN SCI . 129(9): 823-837. Nº de citas: 41

    [doi:10.1042/CS20150111]

  • Petrov D, Pedrós I, Artiach G, Sureda FX, Barroso E, Pallàs M, Casadesús G, Beas-Zarate C, Carro E, Ferrer I, Vazquez M, Folch J and Camins A.

    High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1852(9): 1687-1699. Nº de citas: 131

    [doi:10.1016/j.bbadis.2015.05.004]

  • Palomer FX, Capdevila-Busquets E, Botteri G, Davidson MM, Rodríguez C, Martínez-González J, Vidal F, Barroso E, Chan TO, Feldman AM and Vazquez M.

    miR-146a targets Fos expression in human cardiac cells

    DISEASE MODELS & MECHANISMS . 8(9): 1081-1091. Nº de citas: 36

    [doi:10.1242/dmm.020768]